Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex Vaccine
Clinical trial NCT00224471 · COMPLETED
Trial details
- NCT number
- NCT00224471
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Primary completion
- 2005-09-01
- Enrollment
- 671
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.